Equity
€3.0m ▲ 11.0%
MORPHEO has made a profit in every financial year since 2018.
MORPHEO
Lifetime
8 annual accounts with figures on one time axispeak €948,326 (2018)
€658,458▼ 10.6%
peak €521,894 (2018)
€403,296▼ 7.4%
peak €3.0m (2025)
€3.0m▲ 11.0%
€76,241▲ 69.0%
Board2 names since 2017
1 director
Documentsfilings and deeds
14-10-202675 days late
2025abbreviated format
Dividend €106,952Debts from €45,107 to €76,241Cash from €790,732 to €1.1m
Key points
from the 2025 annual accountsFilings
8 annual accounts 9 filings, 75 days
Latest accounts filed late: after the legal deadline.
Position in the sector
97.5%
Higher solvency than 95% of companies in human health. Sector median 59.4% · 2,809 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,783 companies had the same profile as MORPHEO has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,783 companies, not a prediction for MORPHEO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0686765542
Company renamed from KERSTMEDICAL to MORPHEO
Registered office moved within Sint-Genesius-Rode · New registered office: Terkluizendreef 47, 1640 Sint-Genesius-Rode · Previous registered office: Drève de l'Ermite 47, 1640 Rhode Saint Genèse · Gazette deed
Registered office moved from La Hulpe to Sint-Genesius-Rode
New registered office: Drève de l'Ermite 47, 1640 Rhode Saint Genèse · Previous registered office: rue Clément Delpierre 74B, 1310 LA HULPE · General meeting of 12-05-2023 · Gazette deed
Director in office: (manager)
Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MORPHEO Sint-Genesius-Rode | €3.1m | €658,458 | 97.5% | - |
| AD Jade Vosselaar | €2.8m | €639,514 | 94.4% | - |
| BIROMED Leuven | €2.4m | €673,096 | 97.3% | - |
| Radiologie Dr. Favoreel Ghent | €2.7m | €750,945 | 23.2% | 5.4 |
| BOFace Diepenbeek | €3.0m | €799,983 | 49.8% | - |
| DR. BRIJS STEFAAN, MEDISCHE BEELDVORMING Nazareth-De Pinte | €2.6m | €661,555 | 93.8% | - |
| Radio Peters Beersel | €2.2m | €761,012 | 94.5% | - |
These companies have the same main activity as MORPHEO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.2m and €3m, founded between 2014 and 2019.
Official details
Source: KBO- Status
- Active since 22-12-2017Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.271.458.9951180 Uccle, since 22-12-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 03-10-2026
Insights on MORPHEO
MORPHEO files the abbreviated format. That format states no turnover. The gross margin fell from €948,326 in 2018 to €658,458 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MORPHEO
- What is the company number of MORPHEO?
- The company number of MORPHEO is 0686.765.542. The VAT number is the same number with BE in front: BE 0686.765.542.
- Where is MORPHEO based?
- The registered office is at Terkluizendreef 47, 1640 Sint-Genesius-Rode.Company details
- What does MORPHEO do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of MORPHEO?
- MORPHEO is a private limited company (BV).
- When was MORPHEO founded?
- MORPHEO was founded on 22-12-2017.
- Is MORPHEO still active?
- Yes, MORPHEO is an active enterprise in the KBO register.
- What is the turnover of MORPHEO?
- The turnover in financial year 2025 is ≈ €990,000. This figure is estimated from the gross margin of €658,458 and 31 comparable companies (NACE 86220). It probably lies between €880,000 and €1.4m.Financials
- Is MORPHEO profitable?
- In financial year 2025, MORPHEO made a profit of €403,296.
- Where can I find the annual accounts of MORPHEO?
- MORPHEO filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MORPHEO due?
- MORPHEO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.